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Background: Antimicrobial peptides (AMPs) from the skin secretions of amphibians are now 
considered as a potential alternative to conventional antibiotics. Phylloseptins are a family of 
AMPs identified in the skin secretions of Phyllomedusinae tree frogs which exhibit highly con-
served structural characteristics. This study examines the structure–activity relationship of the 
newly discovered phylloseptin, Phylloseptin-PHa (PSPHa) from Pithecopus hypochondrialis. 
Materials and methods: PSPHa and modified analogs were produced by solid phase syn-
thesis and purified by reverse-phase HPLC. Rationally designed modified analogs incorporat-
ing changes in significant physicochemical parameters such as hydrophobicity, hydrophobic 
moment and net charge were investigated to determine their influence on secondary structure, 
antimicrobial activity, membrane permeabilization and cytotoxicity. 
Results: Overall, we found that when rationally designing AMPs by altering their primary 
structure it is important to keep a balance between hydrophobicity and charge. 
Conclusion: This study provides new insights which will help in the future development of 
AMPs as alternatives to conventional antibiotics for the treatment of Staphylococcus aureus 
and methicillin-resistant S. aureus infections.
Keywords: phylloseptin, antimicrobial activity, hydrophobicity, charge, membrane selectivity
Introduction
Over the past few years, it has become more difficult to treat many infections due to 
development of antibiotic resistance in many of the pathogenic bacteria responsible. 
Therefore, focusing on the discovery of new antimicrobial therapies to alleviate the 
pressures on conventional antibiotics is important to treat these infections. Antimi-
crobial peptides (AMPs) are considered as one of the best alternatives to conventional 
antibiotics due to the fact they are small molecules and they often have broad-spectrum 
antimicrobial activity as well as relatively low cytotoxicity. AMPs are ancient com-
ponents of the innate immune system in all kingdoms of life, which represent the first 
line of defense to bacterial infections.1
Phylloseptins are a family of AMPs widely found in the skin secretions of Phyllo-
medusinae tree frogs. Members of this family of AMPs share several common features, 
such as 19 amino acids with C-terminal amidation, a highly-conserved N-terminal 
“FLSLIP” motif, a cationic amphiphilic structure, an α-helical domain and they are 
rich in Lys/His amino acid residues.2 Phylloseptins also possess potent antimicrobial 
activity due to their disruption of the bacterial membrane.3 Indeed, it is speculated 
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that these cationic peptides bind to the bacteria membrane 
surface due to the electrostatic attraction, and then adopt a 
helical amphipathic structure that promotes their insertion 
into the membrane, or they damage the bacterial membrane 
directly, compromising the bacterial membrane and causing 
their death.4
Phylloseptin-PHa (PSPHa) (Accession: SMY10434) is a 
member of the phylloseptin AMP family, which was previ-
ously identified from the skin secretions of Pithecopus (recti-
fied from Phyllomedusa) hypochondrialis.5 It exhibited potent 
antimicrobial activity, but low hemolytic activity, suggesting 
it could represent a promising antimicrobial. In addition, 
although, ~50 phylloseptins have been discovered so far, stud-
ies on their structure–activity relationship have been limited. 
Therefore, to further probe the structure–activity relationship 
of these AMPs, we investigated the influence of charges and 
hydrophobicity on the bioactivity of PSPHa, to further supple-
ment our understanding of the phylloseptin family of AMPs.
Materials and methods
Peptide synthesis
Peptides were synthesized using Fmoc chemistry method 
as described previously.6 The cleavage cocktail contains 
trifluoroacetic acid (TFA)/ethanedithiol/thioanisole/water 
(94:2:2:2 [v/v]) for 2 hours at room temperature. The pep-
tide was washed using cold diethyl ether and dissolved in 
0.05% TFA/99.95% water (v/v). Each peptide was purified 
by reverse-phase (RP) HPLC and structure verified by Matrix 
Assisted Laser Desorption/Ionization-Time of Flight Mass 
Spectrometry (MALDI-TOF).
comparison of hydrophobicity of 
peptides by rP-hPlc
0.5 mg of each peptide was mixed and dissolved in 1 mL 
of 80% acetonitril/19.95% water/0.05% TFA (v/v) solu-
tion, and 10 µL of mixture was injected into a C18 column 
(Columbus 5 µ C18 110A 250×2.00 mm 5 µ micro 197475-1) 
using Waters 1525 Binary HPLC Pump and Waters 2707 
Autosampler. The peptides were eluted following the gradi-
ent: 0–10 minutes, 0%–30% ACN; 10–60 minutes, 30%–95% 
ACN. The flow rate was 0.2 mL/min, and the detection wave-
length was 214 nm. The elutes were collected and analyzed 
by MALDI-TOF.
Prediction of physicochemical properties, 
secondary structures of peptides and 
circular dichroism (cD) analyses
The predicted physicochemical properties (hydrophobicity, 
hydrophobic moment and net charges) and helical wheel 
projects of all peptides were obtained using Heliquest (http://
heliquest.ipmc.cnrs.fr/ last accessed on September 06, 2018). 
The net charges were predicted at pH 7.4. The determination of 
secondary structure of peptides was conducted using a JASCO 
J-815 CD Spectropolarimeter (JASCO Inc., Tokyo, Japan) as 
described in the previous study.3 The CD spectrum was ana-
lyzed by BeStSel (http://bestsel.elte.hu/index.php last accessed 
on September 06, 2018) for determination of α-helix content.
antimicrobial assays
The antimicrobial activity was evaluated by minimum inhibi-
tory concentration and minimum bactericidal concentration 
assays using the broth-dilution method as described in the 
previous study.3 Seven different microorganisms were used 
in the assay: the Gram-positive bacteria Staphylococcus 
aureus (NCTC10788), Enterococcus faecalis (NCTC12697) 
and methicillin-resistant S. aureus (MRSA) (NCTC12493); 
the Gram-negative bacteria Escherichia coli (NCTC10418), 
Pseudomonas aeruginosa (ATCC27853) and Klebsiella 
pneumoniae (ATCC 43816); and the fungi Candida albicans 
(NCYC1467). All the strains were cultured in Mueller Hin-
ton Broth (MHB), pH 7.4 (Oxiod, Basingstoke, UK). Each 
peptide was tested at the final concentration from 512 to 1 
µM in twofold dilution. Hundred microliters of microor-
ganism culture and sterilized MHB were applied as growth 
control and blank control, respectively. As the peptide stock 
solution was prepared in dimethyl sulfoxide (DMSO) and a 
1% (v/v) of DMSO was presented during the assays, addi-
tional test with 1% (v/v) DMSO in the microorganism was 
applied as the vehicle control. The positive controls were 
applied as 5 mg/L vancomycin (Sigma-Aldrich, St. Louis, 
MO, USA) for Gram-positive bacteria, 5 mg/L gentamicin 
(Sigma-Aldrich) for Gram-negative bacteria and 5 mg/L 
amphotericin B (Sigma-Aldrich) for C. albicans.
Membrane permeability assay
Membrane permeability assay was conducted on S. aureus 
(NCTC10788) using the SYTOX™ Green Nucleic Acid 
Stain (Thermo Fisher Scientific, Waltham, MA, USA) as 
described previously, with some modifications.7 To obtain 
the fluorescence kinetics of membrane permeabilization, the 
bacterial suspension and peptide solutions were mixed to give 
a final concentration at 10 µM in a black 96-well plate, the 
5 µM SYTOX Green nucleic acid stain was mixed with the 
reaction immediately. Then, the plate was read for 40 minutes 
(interval 5 minutes) directly without incubation and changes 
in membrane permeability were quantified via time-course 
analyses. All the peptides were prepared in 5% Tryptic soy 
broth (TSB) (v/v) in 0.85% NaCl solution (m/v) to achieve 
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the final concentration of 10 µM. The total permeabilized 
cells of S. aureus were prepared by treating with 70% iso-
propanol and further resuspended in 5% TSB/0.85% NaCl 
solution after washing. The S. aureus cells resuspended in 5% 
TSB/0.85% NaCl solution were used as the negative control. 
We also included the background control with SYTOX Green 
dye and 5% TSB/0.85% NaCl solution only.
MTT assay
Cell viability was evaluated by MTT assay as described 
previously.7 Six cancer cell lines were purchased from the 
American Type Culture Collection (ATCC, Manassas, VA, 
USA) and Sigma-Aldrich, respectively, including melanocyte 
MDA-MB-435S (ATCC HTB-129), non-small-cell lung can-
cer NCI-H157 (ATCC CRL-5802), human prostate carcinoma 
PC-3 (ATCC CRL-1435), human colon cancer HCT116 
(ATCC CCL-247), human breast cancer MCF-7 (ATCC HTB-
22) and human glioblastoma astrocytoma U251MG (ECACC 
General Cell Collection: 09063001). MDA-MB-435S, 
U251MG, HCT116 and MCF-7 were cultured in DMEM 
with 10% FBS and 1% penicillin–streptomycin solution 
(Pen–Strep). The other cell lines were cultured in RPMI 1640 
medium with 10% FBS and 1% Pen–Strep. All the peptide 
solutions were prepared in the serum-free culture medium, 
and the growth control was applied without any peptides.
lactate dehydrogenase (lDh) assay
The cancer cell line MCF-7 (ATCC HTB-22) and non-
tumorigenic epithelial cell line MCF10A (ATCC CRL-
10317) were treated with PSPHa and the peptides at the 
concentration of 10 µM. The rate of LDH release from these 
two cell lines was measured using Pierce LDH Cytotoxicity 
Assay Kit (Thermo Fisher Scientific) based on the manufac-
turer’s instruction. MCF-7 was cultured in DMEM with 10% 
FBS and 1% Pen–Strep. MCF10A was cultured in DMEM/
F12 (1:1) with 5% horse serum, 20 ng/mL EGF, 100 ng/mL 
cholera toxin, 0.01 mg/nL insulin and 500 ng/mL hydro-
cortisone. Ten micromolars of each peptide were prepared 
in media. One percent (v/v) TritonX-100% and 1% PBS 
in media were employed as positive control and negative 
control, respectively.
hemolysis assay
The hemolytic assay was performed by treating horse eryth-
rocytes with a range of concentrations of the peptides from 
512 to 1 µM as described previously.3 All the peptides were 
prepared in PBS. The hemolysis of horse erythrocytes in 
PBS and 1% (v/v) Triton-X100 was applied as 0% and 
100% hemolytic controls, respectively. The half maximal 
hemolysis concentration (HC
50
, µM) was utilized to assess 
the hemolytic potential.
statistical analyses
All experiments were repeated at least three times, and error 
bars represent the standard error of mean. Statistical analysis 
was performed using Unpaired t-test (GraphPad Prism 6.01, 
GraphPad Prism Inc., La Jolla, CA, USA).
Results
Peptide design
In this study, the natural peptide PSPHa was utilized as a 
template to design and synthesize a series of peptide analogs 
(Table 1). Briefly, Lys was applied to manipulate the cation-
icity and Ile was employed to adjust the hydrophobicity of 
peptides, respectively. To investigate the impact of charge, 
we substituted Ala7 with Lys to increase the presence of 
positive charge to form the analog PSPHa1. In addition, 
amino acid Val12 was replaced with Ile to form the analog 
PSPHa2, to study the effect of the motif “AISAIS” that is 
a typical motif in medusin family AMPs and is a α-helical 
domain which will potentially increase its antimicrobial 
activity.8 Indeed, a previous study indicates the segment from 
positions 5 to 16 can already form a helical conformation in 
phylloseptin peptides.4 Furthermore, the amino acid Ala,14 on 
the hydrophobic face shown in Figure 1A, was replaced with 
Ile to increase the hydrophobicity in PSPHa3. In addition, 
Table 1 The physiochemical properties of all peptides
Peptide Sequence Hydrophobicity ,H. Hydrophobic 
moment ,µH.
% Helix 
(TFE)
Net charges 
(pH 7.4)
PsPha FlsliPaaisaVsalanhF-nh2 0.799 0.457 41.0 1
PsPha1 FlsliPKaisaVsalanhF-nh2 0.731 0.507 29.2 2
PsPha2 FlsliPKaisaIsalanhF-nh2 0.761 0.537 27.3 2
PsPha3 FlsliPKaisaIsalInhF-nh2 0.839 0.598 36.0 2
PsPha4 FlsliPKIisaIsalInhF-nh2 0.918 0.657 36.1 2
PsPha5 FlsliPKIisaIsalIKhF-nh2 0.897 0.673 40.5 3
Notes: The hydrophobicity, hydrophobic moment and net charges were predicted by heliquest online tool. The helical percentage was calculated from the cD spectra of 
each peptide in 50% TFe/10 mM nh4ac solution using Bestsel online software.
Abbreviations: CD, circular dichroism; PSPHa, Phylloseptin-PHa; TFE, 2,2,2-trifluoroethanol.
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we substituted Ala8 in the hydrophobic face of PSPHa3 with 
Ile to make an analog (PSPHa4) with an intact and continuous 
hydrophobic face (Figure 1A). Finally, PSPHa5 was created 
by replacing Asn17 with Lys to produce a helix dipole that 
could extend the helical structure and potentially increase 
the antimicrobial activity.4
secondary structures analyses
All the peptides exhibited α-helical structures in the membrane-
mimic environment with two negative bands in the CD 
spectra at 208 and 222 nm and a positive band at 193 nm 
(Figure 1B). However, PSPHa4 and PSPHa5 exhibited 
slightly negative ellipticity around 222 nm in 10 mM ammo-
nium acetate solution, indicating that both peptides formed 
the slight helical structures in the aqueous environment. 
The calculated hydrophobicity, hydrophobic moment, net 
charge and the helicity of peptides in the membrane-mimic 
environment are shown in Table 1. Furthermore, the chro-
matogram demonstrated that the order of hydrophobicity 
of each peptide is PSPHa4.PSPHa5.PSPHa3.PSPHa.
PSPHa2.PSPHa1 (Figure 2).
antimicrobial and hemolytic activities
PSPHa and its analogs were assessed for antimicrobial 
activity against several Gram-positive, Gram-negative and 
fungi strains (Figure S1), and the results are summarized in 
Table 2. The parent peptide, PSPHa, had activity against 
S. aureus, C. albicans and MRSA but had no impact upon 
E. coli, E. faecalis, P. aeruginosa and K. pneumonia. 
The cationic-enhanced PSPHa1 displayed more potent 
Figure 1 The structural analysis of PsPha and its analogs.
Notes: (A) The helical wheel of all peptides generated using heliquest software. The arrows denote the direction of hydrophobic moment. (B) The cD spectra of all 
peptides in both 10 mM nh4ac solution and in 50% TFe/10 mM nh4ac solution at the concentration of 100 µM.
Abbreviations: CD, circular dichroism; PSPHa, Phylloseptin-PHa; TFE, 2,2,2-trifluoroethanol.
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antimicrobial activity against S. aureus, C. albicans and 
MRSA, as well as activity against all the other microorgan-
isms, except P. aeruginosa. PSPHa2 exhibited similar results 
to PSPHa1, but was more potent again against S. aureus, 
C. albicans, and slightly less potent toward E. faecalis. The 
hydrophobicity-enhanced PSPHa3 showed the strongest 
activity against the Gram-positive bacteria (S. aureus) and 
fungi (C. albicans), and also had activity against MRSA 
and E. faecalis, although it had no impact upon E. coli, 
P. aeruginosa and K. pneumonia. However, the most hydro-
phobic analog, PSPHa4, showed poorer activity than PSPHa3 
against everything except S. aureus. Finally, PSPHa5 showed 
activity against S. aureus, C. albicans, MRSA and E. faecalis, 
but no impact upon E. coli, P. aeruginosa and K. pneumoniae. 
The hemolytic activities of these peptides were also assessed 
(Figure S2), and the HC
50
 values are summarized in Table 3. 
PSPHa had a relatively low hemolytic activity, and the 
cationic-enhanced PSPHa1 had a dramatically reduced 
activity in comparison. However, PSPHa2 exhibited more 
hemolytic activity than either of these and PSPHa3, PSPHa4 
and PSPHa5 showed a dramatic drop in their HC
50
 values 
indicating significant hemolytic activity (Figure S3).
Membrane permeabilization on S. aureus
The ability of PSPHa and the analogs to permeabilize 
S. aureus were also examined, and the different peptides were 





     0LQXWHV
$8
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363+D363+D 363+D 363+D 363+D363+D
Figure 2 The region of reverse-phase hPlc chromatogram for all the peptides.
Notes: The retention time of each peptide is indicated by the arrows. The acetonitrile gradient is marked by a dotted line.
Table 2 Mic/MBc of PsPha and the analogs against selected microorganisms
Strains MIC/MBC (µM)
PSPHa PSPHa1 PSPHa2 PSPHa3 PSPHa4 PSPHa5
Staphylococcus aureus 8/16 8/8 4/4 2/2 2/2 2/2
Escherichia coli .512/.512 128/128 64/128 .512/.512 .512/.512 .512/.512
Candida albicans 32/32 16/32 8/16 4/4 32/128 32/128
Mrsa 64/128 16/32 16/32 32/32 128/256 64/128
Enterococcus faecalis .512/.512 32/32 64/64 32/32 32/64 16/32
Pseudomonas aeruginosa .512/.512 .512/.512 .512/.512 .512/.512 .512/.512 .512/.512
Klebsiella pneumoniae .512/.512 256/512 256/512 .512/.512 .512/.512 .512/.512
Abbreviations: hc50, half maximal hemolysis concentration; MBc, minimum bactericidal concentration; Mic, minimum inhibitory concentration; Mrsa, methicillin-resistant 
S. aureus; PsPha, Phylloseptin-Pha.
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found to exhibit dramatically different impacts when used 
at 10 µM (Figure 3). PSPHa3–5 induced a rapid and total 
uptake of dye within a few minutes (Figure 3A), but the other 
three phylloseptins resulted in a low degree of membrane 
permeabilization and even after 2-hour incubation, ,30% 
of the S. aureus showed permeabilization (Figure 3).
cell viability
PSPHa and its analogs were next assessed for any impact 
on the viability of selected cancer cell lines by MTT assays 
(Figure S4), and the median lethal dose (LD
50
) results are sum-
marized in Table 3. Generally, PSPHa, PSPHa1 and PSPHa2 
exhibited similar impacts upon all the cancer cells examined, 
although PSPHa2 showed a slightly lower LD
50
 for MDA-
MB-435S cells. However, PSPHa3, PSPHa4 and PSPHa5 had 
dramatically lower LD
50
s against all the cell lines, with the 
LD
50
 of PSPHa5 being ,5 µM for all the cell lines examined.
lDh assay
To further explore the impact of PSPHa and its analogs on 
cancer and normal cell viability, we next examined their 
impact upon the breast cancer cell line MCF-7 and the normal 
breast epithelial cell line MCF10A using the LDH assay 
(Figure 4). PSPHa1 induced the lowest degree of LDH release 
for both MCF-7 and MCF10A, and had a significantly greater 
impact upon the cancer cells. PSPHa2–5 exhibited potent 
effects on both the cancer and normal cells, suggesting they 
disrupt the cell membrane of both cell lines. PSPHa was not 
as potent as PSPHa2–5 and induced a slightly more potent 
effect on MCF-7 than the normal breast cells.
Discussion
In the phylloseptin family, most members exhibit antimi-
crobial activity against a range of microorganisms, although 
they tend to be more potent against Gram-positive bacteria 
than the others.9 Indeed, PSPHa has antimicrobial activity 
against Gram-positive bacteria and fungi, while it shows 
no inhibitory activity against Gram-negative bacteria. 
Five analogs were designed and synthesized to investigate 
the structure–activity relationship of this peptide with the 
impact of cationicity, hydrophobicity and amphipathicity 
on its antimicrobial activity, membrane permeabilization 
and cytotoxicity.
Cationicity has been considered as the significant factor 
that ensures the electrostatic interaction between the 
negatively charged lipopolysaccharides and phospho-
lipids on the cell membrane and the cationic peptides,10 
although the impact of positive charge on the bioactivities 
of phylloseptins has been shown to depend on the balance 
with hydrophobicity. As observed in this study, enhanced 
cationicity increased the antimicrobial activity (PSPHa1 
vs PSPHa; PSPHa5 vs PSPHa4). This indicates that the 
net positive charges of phylloseptins have an important 
role in regard to their antimicrobial activities, and that the 
positively charged Lys enhances binding of the peptide to 
the bacterial membrane.11 In contrast, the peptide with the 
lowest hydrophobicity had the least impact upon cancer 
cell viability (PSPHa1), whereas the impact upon cancer 
cell viability was increased with higher hydrophobicity 
(PSPHa5). Therefore, while improving the charge status is 
beneficial to the electrostatic attraction to the anionic bilayer 
of the bacteria, it has less impact against the zwitterionic 
bilayer of mammalian cells. However, the permeabilization 
of mammalian cell membranes relies upon the hydrophobic 
interaction between the hydrophobic helix domain and the 
acyl domain of the cell membrane.12 In addition, improv-
ing the amphipathicity of the α-helical structure can lead 
to a non-selective membrane disruption effect,13 illustrated 
by the increased activity of PSPHa5 against bacterial and 
mammalian cells.
Table 3 The lD50 of PsPha and the analogs against selected human cancer cell lines using MTT assay and their respective hc50 on 
horse erythrocytes
Cell lines LD50 of MTT assays (HC50 of hemolysis on erythrocytes) (µM)
PSPHa PSPHa1 PSPHa2 PSPHa3 PSPHa4 PSPHa5
erythrocytes 52.17 197.7 34.86 9.266 2.766 1.074
MB435s 28.48 32.41 19.56 3.994 4.802 3.553
h157 37.61 41.73 35.34 2.865 2.265 3.614
Pc-3 37.96 32.89 35.11 9.164 9.35 4.256
U251Mg 34.67 33.65 36.46 10.85 9.547 4.059
hcT116 36.64 35.16 37.4 11.71 6.779 4.421
McF-7 24.05 45.69 26.49 10.48 15.01 3.753
Abbreviations: hc50, half maximal hemolysis concentration; PsPha, Phylloseptin-Pha.
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The overall hydrophobicity had a mixed impact upon the 
antimicrobial activity of these phylloseptins. As reported 
using transmission electron microscopy, phylloseptin kill 
S. aureus directly through disrupting the plasma membrane.14 
Increased hydrophobicity does appear to correlate with 
increased activity against S. aureus, but this was not the case 
for the other strains. Indeed, as the hydrophobicity increased 
any impact upon E. coli and K. pneumoniae was lost, and the 
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Figure 3 Membrane permeabilization of gram-positive bacteria Staphylococcus aureus as indicated by an increase in the fluorescence of SYTOX Green dye.
Notes: (A) Kinetic dye uptake effect of PsPha and the analogs against S. aureus at the concentration of 10 µM over 30 minutes. (B) The end point of membrane 
permeabilization after 2-hour incubation with 10 µM of each peptide. The percentage was calculated by the uptake effect induced by 70% isopropanol-treated S. aureus. The 
negative control employed the dye uptake effect of untreated S. aureus suspension in 5% TsB/0.85% nacl solution. The error bar represents the sD, and all samples contained 
five replicates. The significance was calculated using unpaired t-test and indicated by ***P,0.01 and **P,0.05.
Abbreviation: PsPha, Phylloseptin-Pha.
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effects against C. albicans and MRSA did not appear to be 
dependent on the hydrophobicity.
As known, the lipopolysaccharide (LPS) layer of outer 
membrane of Gram-negative bacteria prevents the diffusion 
of hydrophobic molecules through the outer membrane,17 
which protects the plasma membrane from permeabilization. 
Therefore, the very hydrophobic analogs could be blocked 
to reach the cell membrane by the LPS outer membrane, 
leading to the loss of antimicrobial effects of AMPs against 
Gram-negative bacteria.
Regarding Gram-positive bacteria, they possess a thick 
peptidoglycan layer that is cross-linked into a mesh-like 
framework. However, the thickness of the cell wall of Gram-
positive bacteria varies in different strains. It is reported that 
the antibiotic-resistant S. aureus possesses a thicker cell wall 
than normal S. aureus.18 In addition, the hydrophilicity of 
peptidoglycan may decrease the binding affinity between cell 
wall and hydrophobic peptides. This could explain why these 
phylloseptins demonstrated a lower antimicrobial activity 
against MRSA and E. faecalis which are more hydrophilic 
than S. aureus. Indeed, the highly hydrophobic analogs 
can disrupt S. aureus membrane integrity quickly and to a 
much greater extent than those with weaker hydrophobicity. 
Phylloseptins have been reported to adopt a helical structure 
and align parallel to the membrane, then they insert into the 
bilayer to form a transmembrane pore.19 The insertion of 
peptides depends on the hydrophobic interaction with acyl 
group of bilayers, therefore, the hydrophobic analogs could 
interact with the membrane more easily.
From another point, we observed that PSPHa5 and 
PSPHa4 did not have the random coil but the folded structures 
in the aqueous environment. The peptides containing alternat-
ing hydrophobic and hydrophilic amino acids promote the 
formation of peptide dimer due to the strong hydrophobic 
interaction,15 or generate the nanostructures, like nanofibers.16 
Such superstructure makes obstacles for peptides to trans-
locate from the cross-linked peptidoglycan in the cell wall 
of Gram-positive bacteria or the outer membrane of Gram-
negative bacteria to the plasma cell membrane.
The cytotoxicity and hemolytic impact of the phyllo-
septins are regarded as the main obstacles to their develop-
ment as new antimicrobials,20 and the hemolytic activity of 
the phylloseptins examined here is directly correlated with 
increasing hydrophobicity. We also noted that most natu-
rally occurring phylloseptins exhibited different hemolytic 
activity and the significant hemolysis is only observed once 
the hydrophobicity is more than approximate 0.73 (Table 4). 
It indicates that the reduction of hemolysis of phylloseptin 
could be achieved if the hydrophobicity remains below that 
threshold. In addition, it has been shown that increasing net 
charge to +6 while the hydrophobicity is maintained under 
0.73 could contribute to the enhanced antimicrobial activity 
without damaging the erythrocytes.3
PSPHa1 exhibited distinct effects between normal mam-
malian cells and cancer cells, which is consistent with the 
7ULWRQ; 363+D 363+D 363+D 363+D 363+D 363+D 3%6
/'+UHOHDVH 
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Figure 4 lDh release from human breast cancer cell line McF-7 and normal breast 
cell line McF10a induced at the concentration of 10 µM of each peptide.
Notes: The 100% lDh release effect was induced by 1% TritonX-100. The error 
bars represent the SD, and all samples had five replicates. The significance was 
calculated using unpaired t-test and indicated by ***P,0.01.
Abbreviations: lDh, lactate dehydrogenase; PsPha, Phylloseptin-Pha.
Table 4 The physiochemical properties, antimicrobial activity and hemolytic activity of published naturally occurring phylloseptins
Peptide MIC (µM) Hydrophobicity 
,H.
Hydrophobic 
moment ,µH.
Net charges 
(pH 7.4)
HC50
Staphylococcus 
aureus
Escherichia 
coli
Candida 
albicans
Psn-Pc20 2 8 2 0.754 0.563 +2 23
Ps-PTa5 4.1 16.6 2.1 0.740 0.577 +2 22.8
Ps-Du23 3.90 62.5 7.8 0.725 0.624 +2 95
Ps-PBa22 4.2 67.6 4.2 0.711 0.637 +2 90
Ps-co23 4.1 64.9 8.1 0.706 0.636 +2 115
Ps-PT3 264 .264 264 0.707 0.418 +2 .264
Abbreviations: hc50, half maximal hemolysis concentration; Mic, minimum inhibitory concentration.
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hypothesis that AMPs specifically recognize the negatively 
charged surface of cancer cells and that such interactions 
may involve the overexpressed O-glycosylated mucins, or 
alterations in the carbohydrate portion of glycoproteins and 
glycolipids, including increased sialylation and the presence 
of glycosaminoglycans.21 These results would also indicate 
that maintaining the hydrophobicity of phylloseptins around 
0.73 and increasing the net positive charge could be an 
appropriate approach to improve the potential therapeutic 
properties of these phylloseptins.
In summary, our study revealed the specific structure–
activity relationship in regard to the charge and hydrophobicity 
of phylloseptins. Increasing the hydrophobicity, particularly 
on the hydrophobic face, correlated with enhanced membrane 
permeabilization, whereas increasing the charge when the 
hydrophobic range was low, benefited the selectivity. There-
fore, it is feasible to design a peptide which not only possesses 
a broad-spectrum antimicrobial activity but also exhibits negli-
gible cytotoxicity, as an alternative to conventional antibiotics.
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Figure S1 The antimicrobial activity of each peptide against the selected microorganisms from 512 to 1 µM.
Notes: The growth control was presented as bacteria culture without peptides. The vehicle control was employed a final concentration of 1% (v/v) DMSO. The sterilize 
control employed fresh MhB. The positive controls were applied as 5 mg/l vancomycin for gram-positive bacteria, 5 mg/l gentamicin for gram-negative bacteria and 5 mg/l 
amphotericin B for C. albicans. Bars show the mean and the error bars show the standard error from five independent experiments.
Abbreviations: DMsO, dimethyl sulfoxide; MhB, Mueller hinton Broth; Mrsa, methicillin-resistant S. aureus; PsPha, Phylloseptin-Pha.
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Figure S2 The hemolytic activity of each peptide on horse erythrocytes from 512 to 1 µM.
Notes: 1% TritonX-100 and PBs were employed as positive control and negative control, respectively. Bars show the mean and the error bars show the standard error 
from five independent experiments.
Abbreviation: PsPha, Phylloseptin-Pha.
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Figure S3 The hc50 of each peptide on horse erythrocytes.
Notes: Bars show the mean and the error bars show the standard error from five independent experiments. P-value was calculated using unpaired t-test, indicating 
significance ***P,0.001.
Abbreviations: hc50, half maximal hemolysis concentration; PsPha, Phylloseptin-Pha.
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Figure S4 The MTT assays of each peptide against the selected cancer cell lines.
Notes: The cell viability of growth control (cell growth without peptides) was applied as 100% cell viability. Bars show the mean and the error bars show the standard error 
from five independent experiments.
Abbreviation: PsPha, Phylloseptin-Pha.
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